Trial Information

Summary: A phase II, study to assess the safety and effect on ventricular rate of multiple oral doses of study drug in adult subjects with atrial fibrillation

To evaluate the safety and effect on ventricular rate of four escalating oral doses of study drug administered once a day in adult subjects with atrial fibrillation and a rapid ventricular response.

Several Study Inclusion Criteria Include:

• Be able to perform an exercise stress test on a treadmill
• Have adequate anticoagulation therapy according to the physician
• Be 18 years of age or older

Several Study Exclusion Criteria Include:

• Atrial flutter
• Within 30 days, had an MI, acute coronary syndrome, cardiac surgery or a CVA(stroke)
• Untreated alcoholism or drug addiction

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: February 25, 2008 at 2:32:24 PM